Back to search

Article

Novel molecular biomarkers to guide treatment-decision making in metastatic urothelial cancer - A patient cohort analysis

2025-04-04

Abstract excerpt

The current options and recent developments in the field of systemic therapy for advanced urothelial cancer (UC) patients, urges the need for selection criteria to identify the most optimal therapeutic option for individual patients. The molecular makeup of tumors, including molecular subtype, tumor microenvironment composition, gene mutations, fusions and amplifications, has been previously correlated with respon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
273318db-6e30-5660-8fca-a0342e84949c
DOI
10.1101/2025.04.02.25325155
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel molecular biomarkers to guide treatment-decision making in metastatic urothelial cancer - A patient cohort analysisDOI 10.1101/2025.04.02.25325155
Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort Analysis.Semantic proximity
Molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinomaSemantic proximity
The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohortSemantic proximity
Similar genetic profile in early and late stage urothelial tract cancer.Semantic proximity
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancerSemantic proximity
Defining biologically directed therapy target signatures in urothelial carcinoma: A transcriptomic framework for precision therapySemantic proximity
T Cell-to-Stroma Enrichment (TSE) score: a gene expression metric that predicts response to immune checkpoint inhibitors in patients with urothelial cancerSemantic proximity
The genomic and transcriptomic landscape of metastastic urothelial cancer.Semantic proximity
BioBladder – a national longitudinal sampling study providing a comprehensive framework to precision oncology in urothelial cancerSemantic proximity
Integrated Genomic and Single-Cell Analysis Reveals Heterogeneity, Prognosis, and Treatment Vulnerability in Urothelial Carcinoma.Semantic proximity
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial CarcinomaSemantic proximity
The evolving landscape and clinical utility of circulating tumor DNA across the spectrum of urothelial carcinoma: A systematic review and framework for clinical integration.Semantic proximity
Select a neighboring publication to make it the new centre.